CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 709 enrolled / 709 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001813
NCT00001813N/ACompletedHigh Momentum (2.2/mo)

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

National Cancer Institute (NCI)·observational·Posted Nov 4, 1999·Updated Jun 24, 2026

In Brief

An observational study for Cockayne Syndrome and 4 related conditions. Completed, enrolled 709 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. We plan to perform careful clinical examination of selected patients with XP, XP/CS, CS, or TTD and follow their clinical course. We will obtain tissue (skin, blood, hair, buccal swabs) for laboratory examination of DNA repair and for genetic analysis. We hope to be able to correlate these laboratory abnormalities with the clinical features to better understand the mechanism of cancer prevention by DNA repair. Patients will be offered counseling and education for cancer control.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartMay 10, 1999
TodayJul 2, 2026
Posted 26.7 years ago

Arms & Interventions

1other

Subjects with clinical and/or laboratory documentation of typical features or suggestiveclinical features of XP, CS, TTD, or overlap syndromes

2other

Family members of patients with XP, CS, TTD, or overlap syndromes

3other

Healthy volunteers